Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
US-2024009113-A1 · Jan 11, 2024 · US
Compound derived from allulose
US11084805B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11084805-B2 |
| Application number | US-201916491486-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2019 |
| Priority date | Mar 21, 2019 |
| Publication date | Aug 10, 2021 |
| Grant date | Aug 10, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided is a novel compound derived from allulose and a composition comprising the same and having acid resistance.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound in which two molecules of allulose are linked, wherein the compound is 2-(hydroxymethyl)-2-((3,4,5-trihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triol, represented by Formula 1 below: 2. The compound according to claim 1 , wherein the compound is (2S,3R,4R,5R)-2-(hydroxymethyl)-2-(((2R,3S,4R,5S)-3,4,5-trihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triol or (2S,3R,4R,5R)-2-(hydroxymethyl)-2-(((2R,3S,4R,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triol. 3. The compound according to claim 1 , wherein the compound is represented by Formula 3 or 4 below: 4. The compound according to claim 1 , wherein the compound has acid resistance at pH 0.1 to 7. 5. A saccharide composition comprising the compound of claim 1 and a monosaccharide allulose. 6. A composition for a food additive comprising the compound of claim 1 .
Assignees
Inventors
Classifications
- C07H3/04Primary
Disaccharides · CPC title
- C07D407/12Primary
linked by a chain containing hetero atoms as chain links · CPC title
containing sugars or derivatives · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Non-sugar sweeteners · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11084805B2 cover?
- Provided is a novel compound derived from allulose and a composition comprising the same and having acid resistance.
- Who is the assignee on this patent?
- Cj Cheiljedang Corp
- What technology area does this patent fall under?
- Primary CPC classification C07H3/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).